Lyfstone calprotectin

A new advancement in diagnosing PJI
The Lyfstone Calprotectin for synovial fluid is an accurate diagnostic aid that identifies the risk of infection within 15 minutes.
Please leave your details and we will be in touch soon

    Clinic­ally proven

    In a prospective clinical study of 123 patients at a leading US Hospital system using the MSIS-13 criteria as comparator, the Lyfstone Calprotectin test showed excellent sensitivity (98.1%) and specificity (95.7%). The calprotectin test outperformed blood-based PJI diagnostic tests such as CRP and ESR, confirming its diagnostic utility. Source: Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Periprosthetic Joint Infection after Total Knee Arthroplasty: A Prospective Cohort Study. https://clinicaltrials.gov/ct2/show/NCT03694925

    The problem with infections

    Perisprosthetic Joint Infection (PJI) is one of the greatest challenges in orthopaedics. PJI can lead to emotional, financial and physical trauma for patients. A fast and accurate diagnosis of PJI is vital to making the right treatment decisions.

    Read more

    Clear and reliable risk indicators

    The lateral flow rapid test is combined with the Lyfstone app to give an exact quantitative measurement of the level of calprotectin in Synovial fluid. Just hold the smartphone above the sample and align the screen layout with the support frame. The calprotectin concentration and the risk stratification group of the sample is displayed on the screen.
    • LOW risk of infection – CLP levels <14 mg/L
    • MODERATE risk of infection – CLP levels 14<50 mg/L
    • HIGH risk of infection – CLP levels ≥50 mg/L